Literature DB >> 28783509

Dysbiotic Proteobacteria expansion: a microbial signature of epithelial dysfunction.

Yael Litvak1, Mariana X Byndloss1, Renée M Tsolis1, Andreas J Bäumler2.   

Abstract

A balanced gut microbiota is important for health, but the mechanisms maintaining homeostasis are incompletely understood. Anaerobiosis of the healthy colon drives the composition of the gut microbiota towards a dominance of obligate anaerobes, while dysbiosis is often associated with a sustained increase in the abundance of facultative anaerobic Proteobacteria, indicative of a disruption in anaerobiosis. The colonic epithelium is hypoxic, but intestinal inflammation or antibiotic treatment increases epithelial oxygenation in the colon, thereby disrupting anaerobiosis to drive a dysbiotic expansion of facultative anaerobic Proteobacteria through aerobic respiration. These observations suggest a dysbiotic expansion of Proteobacteria is a potential diagnostic microbial signature of epithelial dysfunction, a hypothesis that could spawn novel preventative or therapeutic strategies for a broad spectrum of human diseases.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28783509     DOI: 10.1016/j.mib.2017.07.003

Source DB:  PubMed          Journal:  Curr Opin Microbiol        ISSN: 1369-5274            Impact factor:   7.934


  127 in total

1.  Colonic mucosal and exfoliome transcriptomic profiling and fecal microbiome response to a flaxseed lignan extract intervention in humans.

Authors:  Johanna W Lampe; Eunji Kim; Lisa Levy; Laurie A Davidson; Jennifer S Goldsby; Fayth L Miles; Sandi L Navarro; Timothy W Randolph; Ni Zhao; Ivan Ivanov; Andrew M Kaz; Christopher Damman; David M Hockenbery; Meredith A J Hullar; Robert S Chapkin
Journal:  Am J Clin Nutr       Date:  2019-08-01       Impact factor: 7.045

Review 2.  Pathogen Colonization Resistance in the Gut and Its Manipulation for Improved Health.

Authors:  Joseph M Pickard; Gabriel Núñez
Journal:  Am J Pathol       Date:  2019-05-14       Impact factor: 4.307

3.  Microbiota-nourishing Immunity and Its Relevance for Ulcerative Colitis.

Authors:  Mariana X Byndloss; Yael Litvak; Andreas J Bäumler
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

4.  Effects of Antibiotic Treatment with Piperacillin/Tazobactam versus Ceftriaxone on the Composition of the Murine Gut Microbiota.

Authors:  Carola Venturini; Bethany Bowring; Alicia Fajardo-Lubian; Carol Devine; Jonathan Iredell
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

Review 5.  Host-microbiota interactions in inflammatory bowel disease.

Authors:  Roberta Caruso; Bernard C Lo; Gabriel Núñez
Journal:  Nat Rev Immunol       Date:  2020-01-31       Impact factor: 53.106

Review 6.  Malnutrition, poor post-natal growth, intestinal dysbiosis and the developing lung.

Authors:  Mark A Underwood; Satyan Lakshminrusimha; Robin H Steinhorn; Stephen Wedgwood
Journal:  J Perinatol       Date:  2020-10-14       Impact factor: 2.521

Review 7.  Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome.

Authors:  Larissa S Celiberto; Franziska A Graef; Genelle R Healey; Else S Bosman; Kevan Jacobson; Laura M Sly; Bruce A Vallance
Journal:  Immunology       Date:  2018-05-16       Impact factor: 7.397

8.  Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.

Authors:  Yinghong Wang; Diana H Wiesnoski; Beth A Helmink; Vancheswaran Gopalakrishnan; Kati Choi; Hebert L DuPont; Zhi-Dong Jiang; Hamzah Abu-Sbeih; Christopher A Sanchez; Chia-Chi Chang; Edwin R Parra; Alejandro Francisco-Cruz; Gottumukkala S Raju; John R Stroehlein; Matthew T Campbell; Jianjun Gao; Sumit K Subudhi; Dipen M Maru; Jorge M Blando; Alexander J Lazar; James P Allison; Padmanee Sharma; Michael T Tetzlaff; Jennifer A Wargo; Robert R Jenq
Journal:  Nat Med       Date:  2018-11-12       Impact factor: 53.440

9.  Comparative transcriptome and microbiota analyses provide new insights into the adverse effects of industrial trans fatty acids on the small intestine of C57BL/6 mice.

Authors:  Can Li; Yuhan Zhang; Yueting Ge; Bin Qiu; Di Zhang; Xianshu Wang; Wei Liu; Haiteng Tao
Journal:  Eur J Nutr       Date:  2020-06-20       Impact factor: 5.614

10.  Luminal microbiota related to Crohn's disease recurrence after surgery.

Authors:  Amy L Hamilton; Michael A Kamm; Peter De Cruz; Emily K Wright; Hai Feng; Josef Wagner; Joseph J Y Sung; Carl D Kirkwood; Michael Inouye; Shu-Mei Teo
Journal:  Gut Microbes       Date:  2020-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.